SmartMD 2 minute Health update, (SACKID group Dr. Prakasam): AFREZZA® - A First-in-class Ultra Rapid-Acting Insulin - Inhaled insulin

Wednesday, April 2, 2014

AFREZZA® - A First-in-class Ultra Rapid-Acting Insulin - Inhaled insulin

AFREZZA® - A First-in-class Ultra Rapid-Acting Insulin - Inhaled insulin

FDA Advisory Panel Votes in Favor of Inhaled Insulin Device

FDA Advisory Panel Votes in Favor of Inhaled Insulin Device

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)